MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2025 International Congress

    Theta-Burst Subthalamic Deep Brain Stimulation for Parkinson’s Disease: A Pilot Study of Motor and Cognitive Effects

    X. Mason, K. Wu, M. Abu-Zahra, W. Choi, J. Cavaleri, R. Briggs, C. Mark, B. Lee, M. Wilson, D. Lee (Los Angeles, USA)

    Objective: To evaluate the feasibility and preliminary effects of theta-burst stimulation (TBS) on motor function and verbal fluency in Parkinson’s disease (PD) patients with subthalamic…
  • 2025 International Congress

    Huntington disease in a Patient with Extensive Psychiatric History

    A. Sim, A. Drozdov, D. Carrillo, L. Acosta (El Paso, USA)

    Objective: Huntington's Disease (HD) is an autosomal dominant neurodegenerative disorder resulting from an expansion of CAG trinucleotide repeats in the gene encoding the huntingtin protein.…
  • 2025 International Congress

    Zonisamide for Motor Symptoms and OFF-Time Reduction in Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    J. Pitton Rissardo, A. Fornari Caprara (Camden, USA)

    Objective: To evaluate the efficacy and safety of zonisamide as an adjunct therapy for improving motor function and reducing OFF-time in patients with Parkinson’s disease…
  • 2025 International Congress

    Comparative Analysis of MoCA Scores Between Latin American Latinos and White Patients with Parkinson’s Disease

    S. Sperling, S. Anis, H. Mauricio Chaparro-Solano, T. Peixoto Leal, C. Sonneborn, C. Callegari Piccini, M. Inca-Martinez, M. Cornejo-Olivas, M. Illanes-Manrique, P. Chana-Cuevas, P. Safie Awad, A. Jimena Hernández-Medrano, A. Cervantes-Arriaga, A. Schuh, C. Rieder, P. Braga-Neto, A. Silva Sena, B. Lopes Santos-Lobato, E. Gatto, G. Alvarado, C. Avila, V. Tumas, M. Paula Foss, V. Borges, H. Ballalai Ferraz, J. Orozco Vélez, B. Muñoz Ospina, S. Moreno, D. Pineda, J. Rios Pinto, P. Olguín, J. Cristobal Nuñez, A. Viñuela, A. Espinal-Martinez, N. Mori, K. Mejía-Rojas, A. Medina-Colque, A. Zuma Rosso, C. Vilaça, E. Ochoa-Valle, I. Cornejo-Herrera, P. Reyes-Perez, A. Lázaro-Figueroa, A. Moraes Alves, R. Gisbert Cury, H. Fernandez, I. Mata (Cleveland, USA)

    Objective: The study objectives were to 1) characterize scores on the Montreal Cognitive Assessment (MoCA) in patients with Parkinson’s disease (PD) from Latin America, 2)…
  • 2025 International Congress

    Time perception patterns in patients with Parkinson’s disease and Alzheimer’s disease

    A. Chimagomedova, O. Levin (Moscow, Russian Federation)

    Objective: We conducted this study to assess different patterns of time perception in patients with Parkinson’s disease (PD) and Alzheimer’s disease (AD). Background: Time perception…
  • 2025 International Congress

    Co-Occurrence of DAT Scan, Amyloid PET Scan, and Alzheimer’s Genetic Screening Abnormalities in Patient with Early-Onset Neurocognitive Decline: A Case Report

    A. Mason, R. Payne, N. Shneyder, E. Baldinger (Tampa, USA)

    Objective: The presented case report aims to show the possible overlap between causes of neurocognitive decline and the importance of considering comorbidities when discussing anti-amyloid monoclonal…
  • 2025 International Congress

    Hippocampal-striatal interaction and cognitive decline in Parkinson’s disease with mild cognitive impairment

    S. Tan, X. Zhang, J. Wen, X. Xu, Z. Zhang, J. Xu (Hangzhou, China)

    Objective: We aimed to investigate the interaction between hippocampus and dopaminergic pathways in PD with mild cognitive impairment (PD-MCI). Background: Dysfunction of striatal dopaminergic neurotransmitter…
  • 2025 International Congress

    Performance Validity Test Failure Base Rates Among Presurgical Movement Disorder Patients

    J. Numerick, A. Karstens, D. Gonzalez, D. Ulrich (Chicago, USA)

    Objective: This study investigated the base rates of performance validity test (PVT) failure on neuropsychological testing in a sample of patients seeking surgical intervention (DBS/MRgFUS)…
  • 2025 International Congress

    Cognitive Changes after bilateral Thalamic VIM DBS: A Single Center Experience

    A. Boddu, L. Isaac, J. Newsom, A. Franklin, H. Schweitzer, T. Virmani, E. Petersen, J. Gess (Little Rock, USA)

    Objective: To determine post-surgical cognitive changes and their predictive factors after bilateral ventral intermediate nucleus (VIM) thalamic Deep Brain Stimulation (DBS) in people with essential…
  • 2025 International Congress

    Impact of Over-the-counter Cannabidiol Products on Cognition During the Course of Parkinson’s Disease

    A. López Lobato, D. Náfate Wences, A. Hernández Medrano, A. Cervantes Arriaga, M. Rodriguez Violante (Mexico, Mexico)

    Objective: To evaluate the association between Cannabidiol (CBD) usage and cognitive performance, measured by The Montreal Cognitive Assessment (MoCA) in people living with Parkinson's Disease…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley